Gene variants and risk
The APOE gene is the most important genetic determinant of late-onset Alzheimer's disease. Three main alleles exist: APOE3 is the most common variant, APOE4 is the greatest genetic risk factor known, and APOE2 can delay onset of Alzheimer's by a decade when a person has two copies. Only about 1% of the population has two copies of APOE2.
A dozen or so rare gene variants have been verified as likely contributors to Alzheimer's resilience, though the strength of evidence varies. Three extremely rare variants of APOE3 have been found in people who seem to escape Alzheimer's, and one variant of APOE4 seems to neutralize the risk usually carried by that form.
One rare APOE3 variant, known as the Christchurch variant, affects the receptor-binding region of the ApoE protein and is thought to bind less strongly to receptors, making tau less likely to spread. The other two rare APOE3 variants influence the lipid-binding section, probably making the protein less sticky and less likely to clump and form plaques.